Indian pharma's risk aversion holding back innovation: Kiran Mazumdar-Shaw

Biocon chairperson Kiran Mazumdar-Shaw calls for greater use of digital technology to speed up drug development, as industry leaders push for a shift beyond generics.
Read the full report on The Economic Times
Story file
- Section
- Health
- First reported by
- The Economic Times
- Reporter
- vikas dandekar
- Published
- Sunday, 11 October 2026, 12:13 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from The Economic Times with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.


